117 related articles for article (PubMed ID: 19845742)
1. Severe paraneoplastic pemphigus in a patient with follicular lymphoma.
Krogel C; Fischer T; Heidel F
Eur J Haematol; 2010 Apr; 84(4):365. PubMed ID: 19845742
[No Abstract] [Full Text] [Related]
2. Paraneoplastic pemphigus herpetiformis with IgG antibodies to desmoglein 3 and without mucosal lesions.
Prado R; Brice SL; Fukuda S; Hashimoto T; Fujita M
Arch Dermatol; 2011 Jan; 147(1):67-71. PubMed ID: 21242397
[TBL] [Abstract][Full Text] [Related]
3. Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab.
Aoi J; Makino K; Sakai K; Masuguchi S; Fukushima S; Jinnin M; Inoue Y; Koga H; Hashimoto T; Ihn H
J Dermatol; 2013 Apr; 40(4):285-6. PubMed ID: 23398274
[No Abstract] [Full Text] [Related]
4. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies.
Cozzani E; Christana K; Mastrogiacomo A; Rampini P; Drosera M; Casu M; Murialdo G; Parodi A
Eur J Dermatol; 2007; 17(6):530-3. PubMed ID: 17951135
[TBL] [Abstract][Full Text] [Related]
5. [A case of follicular lymphoma complicated with lethal pemphigus].
Imataki O; Tamai Y; Abe Y; Ito I; Yoshikawa S; Kawakami K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1677-80. PubMed ID: 17108741
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption in pemphigus.
Eming R; Hertl M
Autoimmunity; 2006 Nov; 39(7):609-16. PubMed ID: 17101505
[TBL] [Abstract][Full Text] [Related]
7. A skin rash and what lies beneath: paraneoplastic pemphigus, an atypical presentation of follicular cell lymphoma.
Moustafa MA; Seningen JL; Jouni H; Singh PP; el-Azhary RA; Witzig TE
Am J Hematol; 2013 Sep; 88(9):822-3. PubMed ID: 23658142
[No Abstract] [Full Text] [Related]
8. Rituximab in pemphigus foliaceous with autoantibodies against both Desmoglein 1 and Desmoglein 3.
Carvalho R; Maio P; Cunha D; Freitas I; Afonso A; Cardoso J
Eur J Dermatol; 2011; 21(3):415-6. PubMed ID: 21527367
[No Abstract] [Full Text] [Related]
9. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
10. Atypical pemphigus involving the esophagus with IgG antibodies to desmoglein 3 and IgA antibodies to desmoglein 1.
Inui S; Amagai M; Tsutsui S; Fukuhara-Yoshida S; Itami S; Katayama I
J Am Acad Dermatol; 2006 Aug; 55(2):354-5. PubMed ID: 16844530
[No Abstract] [Full Text] [Related]
11. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL.
Heizmann M; Itin P; Wernli M; Borradori L; Bargetzi MJ
Am J Hematol; 2001 Feb; 66(2):142-4. PubMed ID: 11421295
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic pemphigus without detectable anti-plakin antibodies in a patient with non-Hodgkin lymphoma.
Moreno-Artero E; Querol-Cisneros E; Rodríguez-Garijo N; Tomás-Velázquez A; Idoate MA; Ishii N; Hashimoto T; España A
Ann Hematol; 2018 Mar; 97(3):543-544. PubMed ID: 29143865
[No Abstract] [Full Text] [Related]
13. Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3.
Bouloc A; Joly P; Saint-Leger E; Wechsler J; Roujeau JC; Revuz J
J Am Acad Dermatol; 2000 Oct; 43(4):714-7. PubMed ID: 11004638
[TBL] [Abstract][Full Text] [Related]
14. Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera.
Brandt O; Rafei D; Podstawa E; Niedermeier A; Jonkman MF; Terra JB; Hein R; Hertl M; Pas HH; Müller R
J Invest Dermatol; 2012 Jun; 132(6):1738-41. PubMed ID: 22318391
[No Abstract] [Full Text] [Related]
15. [Desmoglein 1-negative, desmoglein 3-positive pemphigus herpetiformis with involvement of oral mucous membranes].
Brod C; Fierlbeck G; Metzler G; Sönnichsen K; Röcken M; Schaller M
J Dtsch Dermatol Ges; 2005 Apr; 3(4):280-2. PubMed ID: 16370478
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus.
Borradori L; Lombardi T; Samson J; Girardet C; Saurat JH; Hügli A
Arch Dermatol; 2001 Mar; 137(3):269-72. PubMed ID: 11255323
[No Abstract] [Full Text] [Related]
17. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
[TBL] [Abstract][Full Text] [Related]
18. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Cummins DL; Mimouni D; Tzu J; Owens N; Anhalt GJ; Meyerle JH
J Am Acad Dermatol; 2007 Jan; 56(1):153-9. PubMed ID: 17097371
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic pemphigus in a patient with non-Hodgkin's lymphoma.
Plumb R; Doolittle GC
Am J Hematol; 1996 May; 52(1):58-9. PubMed ID: 8638613
[TBL] [Abstract][Full Text] [Related]
20. Blistering mucocutaneous diseases of the oral mucosa--a review: part 2. Pemphigus vulgaris.
Darling MR; Daley T
J Can Dent Assoc; 2006 Feb; 72(1):63-6. PubMed ID: 16480607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
